FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2528366260> ?p ?o ?g. }

• W2528366260 endingPage "17" @default.
• W2528366260 startingPage "12" @default.
• W2528366260 abstract "This retrospective study aimed to evaluate the efficacy of a 3.6-mg dose of pegfilgrastim for primary prophylaxis in Japanese breast cancer patients receiving dose-dense chemotherapy. Patients treated with adjuvant or neoadjuvant chemotherapy for early-stage breast cancer at the Tokyo-West Tokushukai Hospital were included in this analysis. Because 6 mg pegfilgrastim has not yet been approved for use in Japan, we compared the outcomes of a dose-dense doxorubicin and cyclophosphamide regimen plus 3.6 mg pegfilgrastim support with a conventional dose epirubicin and cyclophosphamide regimen. The incidence of febrile neutropenia, relative dose intensity, dose delay, dose reduction, regimen change and hospitalization because of neutropenia were assessed. From November 2013 to March 2016, 97 patients with stage I–III invasive breast cancer were analyzed (dose-dense doxorubicin and cyclophosphamide plus 3.6-mg pegfilgrastim group, n = 41; epirubicin and cyclophosphamide group, n = 56; median ages, 49.0 and 48.5 years, respectively). Febrile neutropenia occurred during the first chemotherapy cycle in 7 of 56 patients (12.5%) in the epirubicin and cyclophosphamide group and 0 of 41 patients in the dose-dense doxorubicin and cyclophosphamide group (P = 0.02). The average relative dose intensities were 97.9% and 96.8%, respectively (P = 0.28), with corresponding dose delay rates of 4.9% (2/41) and 16.1% (9/56), respectively (P = 0.11) and dose reduction rates of 0% (0/41) and 7.1% (4/56), respectively (P = 0.16). Our results indicate the efficacy of a 3.6-mg pegfilgrastim dose for the primary prevention of febrile neutropenia in dose-dense doxorubicin- and cyclophosphamide-treated Japanese breast cancer patients." @default.
• W2528366260 created "2016-10-14" @default.
• W2528366260 creator A5040258765 @default.
• W2528366260 creator A5048221095 @default.
• W2528366260 creator A5049688470 @default.
• W2528366260 creator A5075530194 @default.
• W2528366260 creator A5082214610 @default.
• W2528366260 date "2017-01-01" @default.
• W2528366260 modified "2023-09-26" @default.
• W2528366260 title "Efficacy of reduced dose of pegfilgrastim in Japanese breast cancer patients receiving dose-dense doxorubicin and cyclophosphamide therapy" @default.
• W2528366260 cites W1701849548 @default.
• W2528366260 cites W1972716219 @default.
• W2528366260 cites W2000487326 @default.
• W2528366260 cites W2000900335 @default.
• W2528366260 cites W2024933507 @default.
• W2528366260 cites W2036067444 @default.
• W2528366260 cites W2036450045 @default.
• W2528366260 cites W2050242888 @default.
• W2528366260 cites W2057365773 @default.
• W2528366260 cites W2075213874 @default.
• W2528366260 cites W2081251177 @default.
• W2528366260 cites W2084119896 @default.
• W2528366260 cites W2089265205 @default.
• W2528366260 cites W2098344328 @default.
• W2528366260 cites W2101760255 @default.
• W2528366260 cites W2105417870 @default.
• W2528366260 cites W2118213317 @default.
• W2528366260 cites W2120083524 @default.
• W2528366260 cites W2122122462 @default.
• W2528366260 cites W2135800076 @default.
• W2528366260 cites W2152807596 @default.
• W2528366260 cites W2169403306 @default.
• W2528366260 cites W2338983050 @default.
• W2528366260 doi "https://doi.org/10.1093/jjco/hyw152" @default.
• W2528366260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28122890" @default.
• W2528366260 hasPublicationYear "2017" @default.
• W2528366260 type Work @default.
• W2528366260 sameAs 2528366260 @default.
• W2528366260 citedByCount "6" @default.
• W2528366260 countsByYear W25283662602017 @default.
• W2528366260 countsByYear W25283662602018 @default.
• W2528366260 countsByYear W25283662602019 @default.
• W2528366260 countsByYear W25283662602021 @default.
• W2528366260 crossrefType "journal-article" @default.
• W2528366260 hasAuthorship W2528366260A5040258765 @default.
• W2528366260 hasAuthorship W2528366260A5048221095 @default.
• W2528366260 hasAuthorship W2528366260A5049688470 @default.
• W2528366260 hasAuthorship W2528366260A5075530194 @default.
• W2528366260 hasAuthorship W2528366260A5082214610 @default.
• W2528366260 hasBestOaLocation W25283662601 @default.
• W2528366260 hasConcept C121608353 @default.
• W2528366260 hasConcept C126322002 @default.
• W2528366260 hasConcept C141071460 @default.
• W2528366260 hasConcept C143998085 @default.
• W2528366260 hasConcept C2776694085 @default.
• W2528366260 hasConcept C2776755627 @default.
• W2528366260 hasConcept C2777063308 @default.
• W2528366260 hasConcept C2778658803 @default.
• W2528366260 hasConcept C2778850193 @default.
• W2528366260 hasConcept C2779171977 @default.
• W2528366260 hasConcept C2780835546 @default.
• W2528366260 hasConcept C2781303535 @default.
• W2528366260 hasConcept C2781413609 @default.
• W2528366260 hasConcept C530470458 @default.
• W2528366260 hasConcept C71924100 @default.
• W2528366260 hasConcept C90924648 @default.
• W2528366260 hasConceptScore W2528366260C121608353 @default.
• W2528366260 hasConceptScore W2528366260C126322002 @default.
• W2528366260 hasConceptScore W2528366260C141071460 @default.
• W2528366260 hasConceptScore W2528366260C143998085 @default.
• W2528366260 hasConceptScore W2528366260C2776694085 @default.
• W2528366260 hasConceptScore W2528366260C2776755627 @default.
• W2528366260 hasConceptScore W2528366260C2777063308 @default.
• W2528366260 hasConceptScore W2528366260C2778658803 @default.
• W2528366260 hasConceptScore W2528366260C2778850193 @default.
• W2528366260 hasConceptScore W2528366260C2779171977 @default.
• W2528366260 hasConceptScore W2528366260C2780835546 @default.
• W2528366260 hasConceptScore W2528366260C2781303535 @default.
• W2528366260 hasConceptScore W2528366260C2781413609 @default.
• W2528366260 hasConceptScore W2528366260C530470458 @default.
• W2528366260 hasConceptScore W2528366260C71924100 @default.
• W2528366260 hasConceptScore W2528366260C90924648 @default.
• W2528366260 hasIssue "1" @default.
• W2528366260 hasLocation W25283662601 @default.
• W2528366260 hasLocation W25283662602 @default.
• W2528366260 hasOpenAccess W2528366260 @default.
• W2528366260 hasPrimaryLocation W25283662601 @default.
• W2528366260 hasRelatedWork W180056525 @default.
• W2528366260 hasRelatedWork W2001753354 @default.
• W2528366260 hasRelatedWork W2017611339 @default.
• W2528366260 hasRelatedWork W2042759707 @default.
• W2528366260 hasRelatedWork W2053128632 @default.
• W2528366260 hasRelatedWork W2249531032 @default.
• W2528366260 hasRelatedWork W2528366260 @default.
• W2528366260 hasRelatedWork W2590806005 @default.
• W2528366260 hasRelatedWork W2626058665 @default.
• W2528366260 hasRelatedWork W4310753598 @default.
• W2528366260 hasVolume "47" @default.

• next